JP2014522388A5 - - Google Patents

Download PDF

Info

Publication number
JP2014522388A5
JP2014522388A5 JP2014506792A JP2014506792A JP2014522388A5 JP 2014522388 A5 JP2014522388 A5 JP 2014522388A5 JP 2014506792 A JP2014506792 A JP 2014506792A JP 2014506792 A JP2014506792 A JP 2014506792A JP 2014522388 A5 JP2014522388 A5 JP 2014522388A5
Authority
JP
Japan
Prior art keywords
crystal
acetamide
naphthyl
methoxy
ethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014506792A
Other languages
English (en)
Japanese (ja)
Other versions
JP5770928B2 (ja
JP2014522388A (ja
Filing date
Publication date
Priority claimed from EP11075073.4A external-priority patent/EP2517700B1/en
Application filed filed Critical
Publication of JP2014522388A publication Critical patent/JP2014522388A/ja
Publication of JP2014522388A5 publication Critical patent/JP2014522388A5/ja
Application granted granted Critical
Publication of JP5770928B2 publication Critical patent/JP5770928B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014506792A 2011-04-28 2012-04-25 N‐[2‐(7‐メトキシ‐1‐ナフチル)エチル]アセトアミドの医薬的に許容される共結晶及びそれらの調製方法 Expired - Fee Related JP5770928B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP11075073.4 2011-04-28
EP11075073.4A EP2517700B1 (en) 2011-04-28 2011-04-28 Pharmaceutically acceptable cocrystals of N-[2-(7-methoxy-1-naphthyl]acetamide and methods of their preparation
PCT/EP2012/001761 WO2012146371A1 (en) 2011-04-28 2012-04-25 Pharmaceutically acceptable cocrystals of n-[2-(7-methoxy-1-naphtyl)ethyl]acetamide and methods of their preparation

Publications (3)

Publication Number Publication Date
JP2014522388A JP2014522388A (ja) 2014-09-04
JP2014522388A5 true JP2014522388A5 (enExample) 2015-05-28
JP5770928B2 JP5770928B2 (ja) 2015-08-26

Family

ID=44519907

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014506792A Expired - Fee Related JP5770928B2 (ja) 2011-04-28 2012-04-25 N‐[2‐(7‐メトキシ‐1‐ナフチル)エチル]アセトアミドの医薬的に許容される共結晶及びそれらの調製方法

Country Status (16)

Country Link
US (1) US8927771B2 (enExample)
EP (1) EP2517700B1 (enExample)
JP (1) JP5770928B2 (enExample)
KR (1) KR20140008370A (enExample)
CN (1) CN103501777B (enExample)
BR (1) BR112013023471A2 (enExample)
EA (1) EA024422B1 (enExample)
ES (1) ES2429348T3 (enExample)
IL (1) IL228916A (enExample)
MX (1) MX342807B (enExample)
PL (1) PL2517700T3 (enExample)
PT (1) PT2517700E (enExample)
RS (1) RS52982B (enExample)
UA (1) UA111844C2 (enExample)
WO (1) WO2012146371A1 (enExample)
ZA (1) ZA201307688B (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH12012000132B1 (en) 2011-06-09 2014-10-20 Servier Lab New co-crystals of agomelatine, a process for their preparation and pharmaceutical compositions containing them
EP2551257A1 (en) * 2011-07-28 2013-01-30 Laboratorios Del. Dr. Esteve, S.A. Co-crystals of agomelatine with co-crystal-formers
KR20150020191A (ko) 2012-05-14 2015-02-25 상하이 라이트핸드 팜테크 주식회사 아고멜라틴 산기 복합체와 그의 제조방법 및 용도
US10098859B2 (en) 2012-09-05 2018-10-16 Amri Ssci, Llc Cocrystals of p-coumaric acid
EP2743255B1 (en) 2012-12-17 2016-06-22 Dr. Reddy's Laboratories Ltd. Cocrystal of agomelatine with phosphoric acid
EP2810647A1 (en) * 2013-06-06 2014-12-10 Zentiva, a.s. Pharmaceutical formulations comprising agomelatine in the form of agomelatine co-crystal with an organic acid
ES2645223T3 (es) 2013-06-06 2017-12-04 Zentiva, K.S. Formulaciones de agomelatina que comprenden agomelatina en forma de co-cristales
WO2015013865A1 (en) * 2013-07-29 2015-02-05 Les Laboratoires Servier Agomelatine sulfonic acids complexes and preparation thereof
FR3012142B1 (fr) * 2013-10-17 2016-07-15 Servier Lab Nouveaux complexes d'agomelatine et d'acides sulfoniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
HUE049928T2 (hu) * 2013-07-29 2020-11-30 Servier Lab Agomelatin és szulfonsavak komplexei, eljárás elõállításukra, és ezeket tartalmazó gyógyszerészeti készítmények
CN105473551B (zh) * 2013-07-31 2019-01-11 法国施维雅药厂 阿戈美拉汀和对甲苯磺酸的共晶的新形式、其制备方法和包含其的药物组合物
WO2015013903A1 (en) * 2013-07-31 2015-02-05 Les Laboratoires Servier NEW AGOMELATINE p-TOLUENESULFONIC ACID CO-CRYSTAL FORMS AND PREPARATION THEREOF
PT3036218T (pt) * 2013-07-31 2019-06-11 Shanghai Inst Pharmaceutical Ind Novas formas de co-cristais de agomelatina e ácido p-toluenossulfónico, processo para a sua preparação e composições farmacêuticas que as contêm
KR101404836B1 (ko) 2014-03-21 2014-06-09 순천향대학교 산학협력단 아고멜라틴의 공결정 및 그의 제조방법
KR101470794B1 (ko) * 2014-06-30 2014-12-08 순천향대학교 산학협력단 아고멜라틴 공결정의 제조 방법 및 이를 포함하는 조성물
PL3075724T3 (pl) 2015-03-31 2023-12-27 F.I.S.- Fabbrica Italiana Sintetici S.P.A. Stała postać agomelatyny
WO2017115284A1 (en) * 2015-12-28 2017-07-06 Leiutis Pharmaceuticals Pvt, Ltd. Novel co-crystal forms of agomelatine

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007524596A (ja) * 2003-02-28 2007-08-30 トランスフォーム・ファーマシューティカルズ・インコーポレイテッド 共結晶医薬組成物
AR047553A1 (es) * 2003-07-04 2006-01-25 Lundbeck & Co As H La combinacion de un inhibidor de reabsorcion de serotonina y agomelatina
WO2008035177A2 (en) * 2006-09-18 2008-03-27 Copharm Combination of mt1 and mt2 melatonin receptor agonists and a norepinephrine/dopamine reuptake inhibitor
CN101481321B (zh) * 2009-02-27 2012-04-18 上海医药工业研究院 阿戈美拉汀卤化氢复合物及其制备方法
CN102106806B (zh) * 2009-12-29 2013-04-17 上海中西制药有限公司 一种固体制剂的制备方法及所得固体制剂
WO2012046253A2 (en) * 2010-10-08 2012-04-12 Msn Laboratories Limited Process for the preparation of n-[2- (7-methoxy-l-naphthyl) ethyl] acetamide and its novel crystalline forms
PH12012000132B1 (en) * 2011-06-09 2014-10-20 Servier Lab New co-crystals of agomelatine, a process for their preparation and pharmaceutical compositions containing them

Similar Documents

Publication Publication Date Title
JP2014522388A5 (enExample)
JP2013049690A5 (enExample)
JP2014522413A5 (enExample)
JP2012531408A5 (enExample)
RU2015100280A (ru) Многокомпонентные кристаллы, содержащие дазатиниб и определенные сокристаллобразователи
JP2017522276A5 (enExample)
FI4293009T3 (fi) Fenfluramiinikoostumukset ja menetelmät niiden valmistamiseksi
RU2013158816A (ru) Новые сокристаллы агомелатина, способ их получения и фармацевтические композиции, которые их содержат
JP2007532560A5 (enExample)
JP2016510767A5 (enExample)
JP2019529553A5 (enExample)
JP2011527986A5 (enExample)
JP2018516946A5 (enExample)
JP2019512542A5 (enExample)
JP2018502165A5 (enExample)
HRP20250660T1 (hr) Čvrsti oblici ixazomib citrata
MD4350B1 (ro) Forma cristalină delta a sării de L-arginină a perindoprilului, procedeu de obţinere a ei şi compoziţii farmaceutice care o conţin
JP5802718B2 (ja) (+)および(−)−1−(3,4−ジクロロフェニル)−3−アザビシクロ[3.1.0]ヘキサンの合成のための方法
JP2010540440A5 (enExample)
CN110536888A (zh) 一种苯并哌啶类衍生物的盐、其晶型及盐、其晶型的制备方法
RU2018111482A (ru) Кристаллические формы бедаквилин фумарата и способы их получения
JP2018509421A5 (enExample)
JP2020503330A5 (enExample)
RU2014112315A (ru) Кристаллическая форма бромида тиотропия
JP5488956B2 (ja) (±)2−(ジメチルアミノ)−1−{〔O−(m−メトキシフェネチル)フェノキシ〕メチル}エチル水素サクシナート塩酸塩のI形結晶とII形結晶の混晶の製造法